New Self-Amplifying RNA vaccine shows promise in massive COVID-19 trial
NCT ID NCT05012943
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new type of COVID-19 vaccine called ARCT-154, which uses self-amplifying RNA technology to potentially provide stronger protection. Nearly 20,000 adults in Vietnam, including those with health conditions, received the vaccine or a placebo. Researchers measured safety, immune responses, and how well the vaccine prevented COVID-19.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 VACCINES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hanoi Medical University
Hanoi, Hanoi, 00000, Vietnam
-
Military Medical University
Hanoi, Hanoi, 00000, Vietnam
-
Pasteur Institute
Ho Chi Minh City, Ho Chi Minh, 00000, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.